White papers

This document describes early lessons learnt on the selection of a target disease, on core design choices, and on processes related to the pilot Advance Market Commitment (AMC) for pneumococcal vaccines. While ongoing monitoring and evaluations scheduled for the coming years will provide further information about the value of the Pneumo AMC, this document highlights some of the key lessons to date and aims to provide a starting point to inform discussions about the potential applications of the AMC concept to other vaccines or health and non-health interventions.

Combined with GAVI’s focus on market shaping to decrease prices over time and efforts to raise predictable financing, GAVI’s co-financing policy is a key strategy to ensure long-term sustainability of immunisation programmes in countries receiving GAVI support.

GAVI aims to have a lasting impact on the vaccine market to ensure a sustainable supply of affordable, safe and effective vaccines. To understand how GAVI can be effective in this area, it is important to consider the role and relative importance of the Alliance in the global vaccine marketplace.